GPT and metabolic syndrome: The aims of the present pilot study were to determine whether an in utero environment resulting in LBW is a factor in the compositional development of the gut and hepatic manifestations of metabolic syndrome, specifically altered ALT, and to investigate how a WD may impact these outcomes in growing offspring.